Document Type

Article

Publication Date

2015

Abstract

SGLT2 inhibitors are plausible second-line drugs that provide powerful additional A1c-lowering effects while inducing weight loss without hypoglycemia.

Publisher's Statement

Originally published in Federal Practitioner, 32(Suppl. 11), 10S-17S. Reprinted with permission. This material can be found here.

Share

COinS